These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 31698983)

  • 61. Integrating
    Ntavatzikos A; Spathis A; Patapis P; Machairas N; Peros G; Konstantoudakis S; Leventakou D; Panayiotides IG; Karakitsos P; Koumarianou A
    World J Gastroenterol; 2017 Aug; 23(32):5913-5924. PubMed ID: 28932083
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200.
    Giantonio BJ; Levy DE; O'dwyer PJ; Meropol NJ; Catalano PJ; Benson AB;
    Ann Oncol; 2006 Sep; 17(9):1399-403. PubMed ID: 16873427
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
    Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB; Mulkerin DL; Mayer RJ; Blanke C
    JAMA; 2017 Jun; 317(23):2392-2401. PubMed ID: 28632865
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 65. AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer.
    Pentheroudakis G; Kotoula V; Koliou GA; Karavasilis V; Samantas E; Aravantinos G; Kalogeropoulou L; Souglakos I; Kentepozidis N; Koumakis G; Sgouros J; Zarkavelis G; Efstratiou I; Laschos K; Petraki C; Tikas I; Poulios C; Voutsina A; Goudopoulou A; Bafaloukos D; Vrettou E; Kalogera-Fountzila A; Pectasides D; Fountzilas G
    Clin Colorectal Cancer; 2018 Dec; 17(4):e631-e637. PubMed ID: 29980490
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab.
    Kuramochi H; Ando M; Itabashi M; Nakajima G; Kawakami K; Hamano M; Hirai E; Yokomizo H; Okuyama R; Araida T; Yoshimatsu K; Kameoka S; Hayashi K
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):579-585. PubMed ID: 28213683
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer.
    Sanoff HK; Renfro LA; Poonnen P; Ambadwar P; Sargent DJ; Goldberg RM; McLeod H
    PLoS One; 2014; 9(4):e94727. PubMed ID: 24727911
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm.
    De Mattia E; Polesel J; Roncato R; Labriet A; Bignucolo A; Gagno S; Buonadonna A; D'Andrea M; Lévesque E; Jonker D; Couture F; Guillemette C; Cecchin E; Toffoli G
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.
    Lampropoulou DI; Aravantinos G; Laschos K; Theodosopoulos T; Papadimitriou C; Gazouli M
    Int J Colorectal Dis; 2019 Nov; 34(11):1871-1877. PubMed ID: 31598748
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI.
    De Mattia E; Polesel J; Roncato R; Labriet A; Bignucolo A; Dreussi E; Romanato L; Guardascione M; Buonadonna A; D'Andrea M; Lévesque E; Jonker D; Couture F; Guillemette C; Cecchin E; Toffoli G
    Front Oncol; 2019; 9():1312. PubMed ID: 31850208
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.
    Labriet A; De Mattia E; Cecchin E; Lévesque É; Jonker D; Couture F; Buonadonna A; D'Andrea M; Villeneuve L; Toffoli G; Guillemette C
    Front Pharmacol; 2017; 8():712. PubMed ID: 29066969
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of
    De Mattia E; Cecchin E; Montico M; Labriet A; Guillemette C; Dreussi E; Roncato R; Bignucolo A; Buonadonna A; D'Andrea M; Coppola L; Lonardi S; Lévesque E; Jonker D; Couture F; Toffoli G
    Front Pharmacol; 2018; 9():367. PubMed ID: 29706892
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacogenetic study of CES1 gene and enalapril efficacy.
    Hussain M; Basheer S; Khalil A; Haider QUA; Saeed H; Faizan M
    J Appl Genet; 2024 Jan; ():. PubMed ID: 38261266
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders.
    Hernandez MH; Bote V; Serra-LLovich A; Cendros M; Salazar J; Mestres C; Guijarro S; Alvarez A; Lamborena C; Mendez I; Sanchez B; Hervas A; Arranz MJ
    Pharmgenomics Pers Med; 2022; 15():951-957. PubMed ID: 36393977
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.
    Marin JJG; Monte MJ; Macias RIR; Romero MR; Herraez E; Asensio M; Ortiz-Rivero S; Cives-Losada C; Di Giacomo S; Gonzalez-Gallego J; Mauriz JL; Efferth T; Briz O
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884584
    [TBL] [Abstract][Full Text] [Related]  

  • 76. ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine.
    Juan-Carlos PM; Perla-Lidia PP; Stephanie-Talia MM; Mónica-Griselda AM; Luz-María TE
    Mol Biol Rep; 2021 Feb; 48(2):1883-1901. PubMed ID: 33616835
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients.
    Labriet A; Lévesque É; De Mattia E; Cecchin E; Jonker D; Couture F; Simonyan D; Buonadonna A; D'Andrea M; Villeneuve L; Toffoli G; Guillemette C
    Pharmacogenomics; 2019 Nov; 20(17):1179-1187. PubMed ID: 31698983
    [No Abstract]   [Full Text] [Related]  

  • 78. Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression.
    Obermannová R; Van Cutsem E; Yoshino T; Bodoky G; Prausová J; Garcia-Carbonero R; Ciuleanu T; Garcia Alfonso P; Portnoy D; Cohn A; Yamazaki K; Clingan P; Lonardi S; Kim TW; Yang L; Nasroulah F; Tabernero J
    Ann Oncol; 2016 Nov; 27(11):2082-2090. PubMed ID: 27573561
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients.
    Labriet A; Lévesque É; Cecchin E; De Mattia E; Villeneuve L; Rouleau M; Jonker D; Couture F; Simonyan D; Allain EP; Buonadonna A; D'Andrea M; Toffoli G; Guillemette C
    Sci Rep; 2019 Sep; 9(1):13008. PubMed ID: 31506518
    [TBL] [Abstract][Full Text] [Related]  

  • 80. UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy.
    Yu Q; Zhang T; Xie C; Qiu H; Liu B; Huang L; Peng P; Feng J; Chen J; Zang A; Yuan X
    Cancer Chemother Pharmacol; 2018 Jul; 82(1):87-98. PubMed ID: 29728798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.